Zevra
1 known investors
Zevra Therapeutics develops and commercializes rare disease treatments, including therapies for Niemann-Pick disease type C and urea cycle disorders. The company serves patients with inherited metabolic and genetic disorders through FDA-approved pharmaceutical products.
Founders & leadership
NM
Neil McFarlaneinFounder
Investors Β· 1
Frequently asked questions
- What does Zevra do?
- Zevra Therapeutics develops and commercializes rare disease treatments, including therapies for Niemann-Pick disease type C and urea cycle disorders. The company serves patients with inherited metabolic and genetic disorders through FDA-approved pharmaceutical products.
- Who are Zevra's investors?
- Zevra's investors include HEALTHCARE ROYALTY PARTNERS.